Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 4
2006 4
2007 4
2008 3
2009 2
2010 2
2011 1
2012 1
2015 5
2016 1
2017 1
2018 4
2019 5
2020 5
2021 7
2022 7
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Impact of low and high body mass index on predicting therapeutic efficacy and prognosis in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors.
Takemoto K, Sekino Y, Kitano H, Ikeda K, Goto K, Hieda K, Hayashi T, Hasegawa Y, Kato M, Kadonishi Y, Kajiwara M, Teishima J, Mita K, Maruyama S, Shigeta M, Hinata N. Takemoto K, et al. Among authors: kato m. Int J Urol. 2023 Mar;30(3):319-327. doi: 10.1111/iju.15110. Epub 2022 Nov 30. Int J Urol. 2023. PMID: 36448526
Impact of modified Glasgow prognostic score on predicting prognosis and modification of risk model for patients with metastatic renal cell carcinoma treated with first line tyrosine kinase inhibitor.
Yukihiro K, Teishima J, Goto K, Aoki G, Sekino Y, Hayashi T, Hasegawa Y, Mita K, Kato M, Kajiwara M, Shigeta M, Maruyama S, Kadonishi Y, Fujiwara S, Hinata N. Yukihiro K, et al. Among authors: kato m. Urol Oncol. 2022 Oct;40(10):455.e11-455.e18. doi: 10.1016/j.urolonc.2022.06.016. Epub 2022 Jul 16. Urol Oncol. 2022. PMID: 35851184
Prognostic model of upfront cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors and/or targeted agents.
Teishima J, Goto K, Sekino Y, Mita K, Hayashi T, Hasegawa Y, Kato M, Kajiwara M, Shigeta M, Maruyama S, Kadonishi Y, Fujiwara S, Kobayashi K, Asano K, Hinata N. Teishima J, et al. Among authors: kato m. Int Urol Nephrol. 2022 Jun;54(6):1225-1232. doi: 10.1007/s11255-022-03157-w. Epub 2022 Mar 22. Int Urol Nephrol. 2022. PMID: 35314918
Preliminary evaluation of dual imaging plate intraoral radiography.
Watanabe K, Imanishi Y, Kato M, Kimoto H, Sekiguchi T, Amemiya T, Dezawa K, Matsumoto K, Arai Y, Honda K. Watanabe K, et al. Among authors: kato m. J Oral Sci. 2022 Jan 19;64(1):69-73. doi: 10.2334/josnusd.21-0454. Epub 2021 Dec 27. J Oral Sci. 2022. PMID: 34955492 Free article.
57 results